Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pleural Effusion, Malignant × Saline Solution × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 12 Carcinoma, Non-Small-Cell Lung 7 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Delirium 2 Thromboembolism 1 Small Cell Lung Carcinoma 1 Respiratory Insufficiency 1 Postoperative Complications 1 Pneumonia 1 Pleural Effusion, Malignant 1 Pleural Effusion 1 Neurotoxicity Syndromes 1 Neoplasms 1 Myocardial Infarction 1 Metastatic Non-Squamous Non-Small Cell Lung Cancer 1 Mesothelioma 1 Lung Diseases 1 Inoperable Stage III Non-small Cell Lung Cancer 1 Emergence Delirium 1 Arrhythmias, Cardiac 1 Angina, Unstable 1 Agnosia 1 Acute Coronary Syndrome 1

Interventions

Cisplatin 8 Carboplatin 7 Bevacizumab 7 Talc 6 Pleurodesis 6 Paclitaxel 5 Doxycycline 4 Docetaxel 4 Thoracoscopy 3 Taxes 3 Gemcitabine 3 Zoledronic Acid 2 Trastuzumab 2 Thoracentesis 2 Surveys and Questionnaires 2 Sodium Chloride 2 Silver Nitrate 2 Povidone-Iodine 2 Nivolumab 2 Magnetic Resonance Spectroscopy 2 High-Energy Shock Waves 2 Fluorodeoxyglucose F18 2 Fentanyl 2 Erlotinib Hydrochloride 2 Drug Therapy 2 Chest Tubes 2 Bortezomib 2 viscum album peptide 1 tocilizumab 1 tipifarnib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01411202 2020-09-25

OPUS

Ottawa Hospital Research Institute

Phase 2 Unknown

Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡